The "dual-type pathogenesis" of malignant tumors: a discussion of conception

LING Changquan

doi:10.3969/j.issn.1006-2157.2023.07.023

您当前的位置：

首页 >

文章列表页 >

The "dual-type pathogenesis" of malignant tumors: a discussion of conception

Hematology and Oncology | 更新时间：2023-08-07

- The "dual-type pathogenesis" of malignant tumors: a discussion of conception
- Journal of Beijing University of Traditional Chinese Medicine Vol. 46, Issue 7, Pages: 1032-1036(2023)
- 作者机构：
  
  1.海军军医大学中医系　上海　200433
  2.海军军医大学第一附属医院中医肿瘤科
  3.上海中医药大学中西医结合学院
- 作者简介：
  
  Prof. LING Changquan, Ph. D., Chief Physician, Doctoral Supervisor. School of Traditional Chinese Medicine, Naval Medical University, No.800, Xiangyin Road, Yangpu District, Shanghai 200433. E-mail: changquanling@smmu.edu.cn
- 基金信息：
  
  National Natural Science Foundation of China(82030117);Traditional Chinese Medicine Inheritance and Innovation "Hundred-Thousand-Ten Thousand" Talents Project (Qihuang Project)-National Traditional Chinese Medicine Leading Talents Support Plan Qihuang Scholar of National Administration of Traditional Chinese Medicine;The Second National Famous Traditional Chinese Medicine Inheritance Studio Construction Project of National Administration of Traditional Chinese Medicine
- DOI：10.3969/j.issn.1006-2157.2023.07.023
  CLC： R273
- Received：10 November 2022，
  
  Online First：08 May 2023，
  
  Published：30 July 2023
- 稿件说明：
移动端阅览
LING Changquan. The "dual-type pathogenesis" of malignant tumors: a discussion of conception[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023, 46(7): 1032-1036.
DOI：

LING Changquan. The "dual-type pathogenesis" of malignant tumors: a discussion of conception[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023, 46(7): 1032-1036. DOI： 10.3969/j.issn.1006-2157.2023.07.023.

摘要

恶性肿瘤严重影响人类生命健康安全，中医药可以贯穿于恶性肿瘤防治的全过程。本文以肝癌为例，对恶性肿瘤“双重病机”的概念进行了初步探讨，提出“癌毒盛衰”是恶性肿瘤的特异病机，贯穿本病的始终，初郁、中热、终虚是重要的常规病机转化过程。“双重病机”围绕着特异病机和常规病机之间的兼夹、复合、转化，较为系统地探讨恶性肿瘤的病机演变规律，对解析这类复杂性疾病的发病与转归具有独特的实践意义。

Abstract

Malignant tumors seriously impact the health of human beings

and traditional Chinese medicine can be applied through the whole process of malignant tumor prevention and treatment. Taking liver cancer as an example

the concept of "dual-type pathogenesis" of malignant tumors is preliminarily discussed in this paper. The specific pathogenesis is "exuberance and debilitation of tumor toxin"

which affects the whole course of the disease

while the important routine pathogenesis transformation process is stagnation first

heat second

and finally deficiency. The "dual-type pathogenesis" of malignant tumors reveals the interaction of concurrent symptoms

combined syndrome

and their mutual conversion between specific pathogenesis and routine pathogenesis

and systematically discusses the evolution law of pathogenesis. Therefore

it has unique practical significance for analyzing the pathogenesis and prognosis of complex diseases such as malignant tumors.

关键词

Keywords

references

SUNG H , FERLAY J , SIEGEL R , et al . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries [J]. CA Cancer J Clin ， 2021 ， 71 ( 3 ): 209 - 249 .

World Health Organization . Global health estimates: Leading causes of death [EB/OL]. ( 2021-09-21 ) [ 2022-11-03 ]. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death .

汤钊猷．癌症防控需“消灭＋改造”的持久战：中西医结合值得期待 [J]. 中国中西医结合杂志， 2018 ， 38 ( 2 ): 133 - 135 .

吴孟超．中医药在肝癌防治中的作用、地位和存在的问题 [J]. 中西医结合学报， 2003 ， 1 ( 3 ): 163 - 164 .

ZHAO HT , MENG YB , ZHAI XF , et al . Comparable effects of Jiedu Granule, a compound Chinese herbal medicine, and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort study [J]. J Integr Med ， 2020 ， 18 ( 4 ): 319 - 325 .

ZHAI XF , LIU XL , SHEN F , et al . Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: A randomized controlled study [J]. Cancer ， 2018 ， 124 ( 10 ): 2161 - 2168 .

XIANG YN , GUO ZM , ZHU PF , et al . Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science [J]. Cancer Med ， 2019 ， 8 ( 5 ): 1958 - 1975 .

叶放，周学平，吴勉华，等．周仲瑛教授“复合病机论”探析 [J]. 南京中医药大学学报， 2010 ， 26 ( 4 ): 241 - 244 .

叶放，周学平，周仲瑛．复合病机转化论初探 [J]. 中医杂志， 2010 ， 51 ( 10 ): 869 - 871 .

胡镜清．病机兼化理论框架下的冠心病病机解析 [J]. 中国中医基础医学杂志， 2017 ， 23 ( 1 ): 4 - 7 .

张继泽，单兆伟．张泽生医案医话集 [M]. 南京：江苏科技出版社， 1981 ： 341 .

陈洁娜，李园，丁霞．基于中医脾胃生理功能探讨肿瘤免疫调控 [J]. 北京中医药大学学报， 2023 ， 46 ( 1 ): 32 - 36 .

桑天庆，周红光．基于癌毒理论的恶性肿瘤的从湿论治 [J]. 时珍国医国药， 2020 ， 31 ( 10 ): 2461 - 2463 .

程海波，李柳，周学平，等．中医肿瘤癌毒病机辨证体系的创建 [J]. 中医杂志， 2020 ， 61 ( 20 ): 1767 - 1770 .

凌昌全．恶性肿瘤病因病机之我见 [J]. 中医杂志， 2009 ， 50 ( 10 ): 952 - 953 .

韩尽斌，刘庆，岳小强，等．浅议癌气概念与恶性肿瘤的治疗 [J]. 中医杂志， 2012 ， 53 ( 18 ): 1548 - 1551 .

岳小强．对“癌毒”定义的再认识 [J]. 中西医结合学报， 2010 ， 8 ( 9 ): 829 - 831 .

阳国彬．基于数据挖掘的原发性肝癌辨治规律研究 [D]. 武汉：湖北中医药大学， 2019 .

谢长生，王东建，潘磊，等 . 561例肺癌中医证型与TNM分期及病理类型的相关性探索 [J]. 浙江中医杂志， 2010 ， 45 ( 6 ): 398 - 399 .

易维真，汪晓明，张福忠，等．乳腺癌中医证型与临床分期及分子标志物关系 [J]. 安徽中医学院学报， 2009 ， 28 ( 5 ): 23 - 25 .

张雅明．柏连松运用扶正祛邪法治疗大肠癌的经验 [J]. 上海中医药杂志， 2005 ， 39 ( 9 ): 29 .

刘瑞，花宝金．花宝金运用气机升降理论治疗肝癌经验 [J]. 辽宁中医杂志， 2014 ， 41 ( 12 ): 2552 - 2553 .

王清云．肝癌与情志关系 [J]. 吉林中医药， 2004 ， 24 ( 8 ): 47 .

李晶滢．钱英教授辨治原发性肝癌学术思想及临床经验研究 [D]. 北京：中国中医科学院， 2015 .

欧杰，陈闯，诸佳瑜，等 . 175例原发性肝癌中医证型与BCLC分期相关性研究 [J]. 西部中医药， 2017 ， 30 ( 7 ): 71 - 73 .

楚小鸽，韩慧，马璐璐，等．清热解毒方对小鼠移植性肝癌抗肿瘤作用及趋化因子的影响 [J]. 上海中医药杂志， 2017 ， 51 ( 1 ): 81 - 87 .

YU Y , LANG QB , CHEN Z , et al . The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study [J]. Cancer ， 2009 ， 115 ( 22 ): 5132 - 5138 .

徐光星．何任教授治疗原发性肝癌学术思想探究 [J]. 中华中医药杂志， 2008 ， 23 ( 7 ): 599 - 601 .

凌昌全． “癌毒”是恶性肿瘤之根本 [J]. 中西医结合学报， 2008 ， 6 ( 2 ): 111 - 114 .

王榕平，王莹．原发性肝癌与肝硬化血瘀证的血液流变学测定 [J]. 福建中医药， 1999 ， 30 ( 3 ): 2 - 3 .

Views

364

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Establishment and clinical application of the "three-stage and threedimension" diagnosis and treatment system for metabolic-associated fatty liver disease

Differentiation and analysis of the concepts of "toxin syndrome" syndromes and "cancerous toxin" pathogenesis

"Five-Phase Evolution" ——construction and innovation of a theoretical system for the prevention and treatment of malignant tumors by Taditional Chinese Medicine

Pathogenesis evolution and stage-based treatment of chronic atrophic gastritis based on "Liu Shi Run Zao"

Clinical research on the application of traditional Chinese medicine in malignant hematological diseases after cryoablation of local lesions

Related Author

HU Jiayan

LI Junxiang

MAO Tangyou

WANG Yuxi

LIN Zhengdao

YU Yitong

YANG Anqi

SUN Zhezheng

Related Institution

Dongfang Hospital, Beijing University of Chinese Medicine

Graduate School of Beijing University of Chinese Medicine

Graduate School, Beijing University of Chinese Medicine

Guang’anmen Hospital, China Academy of Chinese Medical Sciences

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences

AI问答

Postal code：100029
Tel：(010)53911857 Email：jbutcm@bucm.edu.cn
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰